From: The broad spectrum of COVID-like patients initially negative at RT-PCR testing: a cohort study
 | Overall Median [IQR] N (%) | COVID-19 Median [IQR] N (%) | COVID-free/other than COVID Median [IQR] N (%) | p |
---|---|---|---|---|
n | 115 | 66 | 49 | Â |
age (years) | 76.17 [58 - 84] | 72.76 [55- 81] | 78.09 [72 - 84] | 0.022# |
sex |  |  |  | 0.275° |
 F | 45 (39.1) | 23 (34.8) | 22 (44.9) |  |
 M | 70 (60.9) | 43 (65.2) | 27 (55.1) |  |
Hypertension |  |  |  | 0.997° |
 No | 54 (47.0) | 31 (47.0) | 23 (46.9) |  |
 Yes | 61 (53.0) | 35 (53.0) | 26 (53.1) |  |
Cardiopathy |  |  |  | 0.342° |
 No | 79 (68.7) | 43 (65.2) | 36 (73.5) |  |
 Yes | 36 (31.3) | 23 (34.8) | 13 (26.5) |  |
COPD |  |  |  | 0.001° |
 No | 93 (80.9) | 60 (90.9) | 33 (67.3) |  |
 Yes | 22 (19.1) | 6 (9.1) | 16 (32.7) |  |
Lung fibrosis |  |  |  | 0.162§ |
 No | 110 (95.7) | 65 (98.5) | 45 (91.8) |  |
 Yes | 5 (4.3) | 1 (1.5) | 4 (8.2) |  |
Lung Cancer |  |  |  | 1.000§ |
 No | 108 (93.9) | 62 (93.9) | 46 (93.9) |  |
 Yes | 7 (6.1) | 4 (6.1) | 3 (6.1) |  |
Cancer |  |  |  | 0.795° |
 No | 95 (82.6) | 54 (81.8) | 41 (83.7) |  |
 Yes | 20 (17.4) | 12 (18.2) | 8 (16.3) |  |
Immunodepression |  |  |  | 0.210° |
 No | 95 (82.6) | 52 (78.8) | 43 (87.8) |  |
 Yes | 20 (17.4) | 14 (21.2) | 6 (12.2) |  |
Neurological disorders |  |  |  | 0.192° |
 No | 78 (67.8) | 48 (72.7) | 30 (61.2) |  |
 Yes | 37 (32.2) | 18 (27.3) | 19 (38.8) |  |
Diabetes or other metabolic conditions |  |  |  | 0.627° |
 No | 71 (61.7) | 42 (63.6) | 29 (59.2) |  |
 Yes | 44 (38.3) | 24 (36.4) | 20 (40.8) |  |
Renal Failure |  |  |  | 0.144° |
 No | 100 (87.0) | 60 (90.9) | 40 (81.6) |  |
 Yes | 15 (13.0) | 6 (9.1) | 9 (18.4) |  |
Total WBC count /μl | 9.24 [6.02 - 13.38] | 7.62 [5.12 - 11.50] | 10.90 [7.48 - 15.20] | 0.005# |
Lymphocyte count/ μl | 1175.00 [792.50 - 1765.00] | 1120.00 [820.00 - 1710.00] | 1410.00 [740.00 - 1870.00] | 0.567# |
LDH U/L | 285.50 [228.00 - 393.00] | 288.50 [243.75 - 380.75] | 272.00 [217.25 - 427.50] | 0.351# |
PCR mg/dL | 4.46 [1.02 - 13.16] | 5.64 [2.15 - 13.23] | 3.48 [0.49 - 12.60] | 0.257# |
PCT ng/mL | 0.07 [0.03 - 0.55] | 0.05 [0.04 - 0.26] | 0.16 [0.03 - 1.05] | 0.151# |
PaO2/FiO2 at arrival | 318 [242 - 357] | 331 [252 - 385] | 322 [247 - 373] | 0.350# |